A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Acerta Pharma BV
Essen Biotech
Essen Biotech
Massive Bio, Inc.
Incyte Corporation
Cedars-Sinai Medical Center
BerGenBio ASA
Taproot Health
Cedars-Sinai Medical Center
Sumitomo Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
Centre Leon Berard
Celgene
Celgene
Novartis
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center